Olaparib in Patients With HRD Malignant Mesothelioma

Abroad (travel likely)RecruitingPHASE2

Conditions

Mesothelioma · Homologous Recombination Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Chicago Medical Center, Chicago, Illinois, United States

Study leads

Hedy L Kindler, MD
Principal Investigator
University of Chicago

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Peritoneal Malignant Mesothelioma

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Chicago, United States

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) · Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy) · Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Baltimore, United States

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma · Pleural Sarcomatoid Mesothelioma

Abroad (travel likely)RecruitingPHASE2

Anchorage, United States · Anchorage, United States

A Study of Sacituzumab Govitecan in People With Mesothelioma

Mesothelioma · Mesotheliomas Pleural · Mesothelioma; Pleura

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States